What is the impact of population screening for CRC?
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Monique Van Leerdam discusses the image of population screening for colorectal cancer (CRC).
Author: imedex
Added: 09/01/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 2, 2016 Category: Cancer & Oncology Source Type: podcasts
Does advanced imaging help in the detection of CRC?
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Nadir Arber discusses whether or not advanced imaging helps in the detection of colorectal cancer (CRC).
Author: imedex
Added: 09/01/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 2, 2016 Category: Cancer & Oncology Source Type: podcasts
Hereditary colorectal cancer and gastric cancer
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Judith Balmaa discusses hereditary colon and gastric cancers.
Author: imedex
Added: 09/01/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 2, 2016 Category: Cancer & Oncology Source Type: podcasts
New targets and new agents in HCC
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Eric Raymond discusses new targets and agents for the treatment of hepatocellular carcinoma (HCC).
Author: imedex
Added: 09/01/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 2, 2016 Category: Cancer & Oncology Source Type: podcasts
Tandem Talk 3: Hepatocellular carcinoma - Locoregional Treatment
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Chris Verslype arguest for the locoregional treatment of hepatocellular carcinoma (HCC).
Author: imedex
Added: 09/01/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 2, 2016 Category: Cancer & Oncology Source Type: podcasts
Tandem Talk 2: The approach for gastric NETs - The clinician's contribution
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Bertram Wiedenmann discusses the clinician's contribution to the approach for gastric neuroendocrine tumors (NET)...
Author: imedex
Added: 08/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 19, 2016 Category: Cancer & Oncology Source Type: podcasts
Tandem Talk 1: Imaging in NET - Contribution of isotopic scanning
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Christophe Deroose discusses the contribution of isotopic scanning to the imaging of neuroendocrine tumors (NET).
Author: imedex
Added: 08/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 19, 2016 Category: Cancer & Oncology Source Type: podcasts
Tandem Talk 1: Imaging in NET - Contribution of CT and MRI
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Timm Denecke discusses the contribution of CT and MRI to the imaging of neuroendocrine tumors (NET).
Author: imedex
Added: 08/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 19, 2016 Category: Cancer & Oncology Source Type: podcasts
New agents on the horizon in gastric cancer
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Florian Lordick discusses new agents on the horizon in gastric cancer.
Author: imedex
Added: 08/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 19, 2016 Category: Cancer & Oncology Source Type: podcasts
Targeting HER 2 and angiogenesis in gastric cancer: What is the impact?
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Andrs Cervantes discusses the impact of targeting HER2 and angiogenesis in gastric cancer.
Author: imedex
Added: 08/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 19, 2016 Category: Cancer & Oncology Source Type: podcasts
Controversy Debate 3: Neo-adjuvant/Adjuvant treatment in gastric cancer - The surgical point of view
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. William H. Allum provides the surgeon's perspective on neo-adjuvant/adjuvant treatment in gastric cancer.
Author: imedex
Added: 08/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 19, 2016 Category: Cancer & Oncology Source Type: podcasts
Controversy Debate 3: Neo-adjuvant/Adjuvant treatment in gastric cancer - The EU view
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. March Ychou provides the EU perspective on neo-adjuvant/adjuvant treatment in gastric cancer.
Author: imedex
Added: 08/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 19, 2016 Category: Cancer & Oncology Source Type: podcasts
Keynote Lecture 1: Unraveling the taxonomy in gastric cancer
In this Keynote Lecture, Dr. Adam Bass examines the taxonomy in gastric cancer.
Author: imedex
Added: 08/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 19, 2016 Category: Cancer & Oncology Source Type: podcasts
Gastric carcinogenesis of gastric cancer through the eyes of a pathologist
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Ftima Carneiro discusses the pathologist's perspective on gastric carcinogenesis of gastric cancer.
Author: imedex
Added: 08/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 19, 2016 Category: Cancer & Oncology Source Type: podcasts
What is the most optimum perioperative treatment in esophageal cancer
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. David H. Ilson examines which is the most optimum perioperative treatment in esophageal cancer.
Author: imedex
Added: 08/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 19, 2016 Category: Cancer & Oncology Source Type: podcasts
